About the Company
We do not have any company description for Calidi Biotherapeutics, Inc. at the moment.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights
Detailed price information for Calidi Biotherapeutics Inc (CLDI-A) from The Globe and Mail including charting and trades.
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to ...
Calidi Biotherapeutics Inc. is taking a bold approach to this challenge with a next-generation platform designed to deliver genetic medicines directly to both primary and metastatic tumors.
Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FL / ACCESS Newswire / August 1, 2025 / RedChip Companies will air interviews with Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision ...
Calidi Biotherapeutics Inc. is committed to developing a novel approach to treating cancer through the precise delivery of genetic medicines to both primary tumors and metastatic sites of disease.
Calidi Biotherapeutics Announces Executive Departure Agreement
Detailed price information for Calidi Biotherapeutics Inc (CLDI-A) from The Globe and Mail including charting and trades.
Calidi Biotherapeutics Announces IL15 Superagonist as First ... - Nasdaq
--Calidi Biotherapeutics Inc., a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the selection of IL15 superagonist as the ...
Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million ...
SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the ...
Calidi Biotherapeutics Announces Pricing of $4.25 Million Public ...
--Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced that it priced its public offering of 5,000,000 ...
Calidi Biotherapeutics Inc trading resumes
Biotherapeutics Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking ...
Calidi Biotherapeutics Inc. (NYSE American: CLDI ... - Morningstar
Calidi Biotherapeutics Inc. is taking a bold approach to this challenge with a next-generation platform designed to deliver genetic medicines directly to both primary and metastatic tumors.
Similar Companies
Loading the latest forecasts...